NORTHVALE, N.J., June 13, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) announced today that OneMedMarkethas released an interview of ADMT President and CEO Andre' DiMino in OneMedMarket's June 12th edition of "The Sentinel Breakthroughs in Health & Medicine / Trends in Finance" in advance of ADMT's presentation
"We would like to thank OneMedMarket for sponsoring ADMT at the upcoming Marcum Conference and for starting to tell our story to their subscriber and investor base," stated Mr. DiMino. "We have seen a steady increase in share trading volume over the past few days since the announcement of OneMedMarket's sponsorship of ADMT at the Conference and the in-depth interview being released."
OneMedMarket's "The Sentinel" featuring the ADMT interview can be seen at http://conta.cc/2tdM34n and a direct link to the complete interview is at http://www.onemednews.com/2017/06/06/andre-dimino-admt/
The Marcum MicroCap Conference has become a nationally recognized forum for publicly traded small cap companies to network with fund managers and high net worth investors who focus on small cap equities. More than 2,000 participants from all segments of the microcap market participate each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts who are active in the microcap marketplace.
Brett Johnson, Founder and CEO of OneMedMarket, stated, "We were asked to search for promising lesser known emerging healthcare companies to present at the Marcum Conference. ADMT is a little known but very impressive company with some very interesting technologies in the area of pain and tinnitus that hold considerable promise. They are also developing a digital platform that capitalizes on the expertise they gained while developing sophisticated medical devices for cutting edge companies. As such we are so pleased to sponsor ADMT to present at the Marcum Conference."
ADMT will be presenting at 2:30 PM on June 15, 2017.
The Marcum MicroCap Conference will be held June 15-16 at the Grand Hyatt Hotel in New York City.
About ADMTADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Medical Device Design, Engineering, Regulatory and Manufacturing Services; Proprietary Electronic Medical Devices; and Eco-Friendly, Water-Based Formulations. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are "forward looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/adm-tronics-ceo-interviewed-by-onemedmarket-in-advance-of-presentation-at-annual-marcum-conference-300473148.html
SOURCE ADM Tronics Unlimited, Inc.
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All